Stay updated with breaking news from Niraj Varma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HeartBeam, Inc. (NASDAQ:BEAT) Q3 2023 Earnings Call Transcript November 14, 2023 HeartBeam, Inc. misses on earnings expectations. Reported EPS is $-0.13 EPS, expectations were $-0.12. Operator: Greetings and welcome to the HeartBeam Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] A question-and-answer session will follow the formal presentation. As a reminder, this conference is […]
Operator: Greetings and welcome to the HeartBeam Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] A question-and-answer session will follow the formal presentation.
SANTA CLARA, Calif.--(BUSINESS WIRE)--Nov 14, 2023--
Resynchronization therapy jumps forward with 3 new studies that support but push the envelope of a new guideline statement on physiologic pacing for heart failure.
In a major medical breakthrough, Cleveland Clinic has implanted the world's first dual cardiac device in a patient as part of a clinical trial aimed at treating heart failure symptoms. It was done by top Cleveland experts Bruce Wilkoff and Niraj Varma.